PREVALENCE OF GESTATIONAL THROMBOCYTOPENIA IN ANTENATAL WOMEN FOLLOWING COVID-19 INFECTION AT A TERTIARY CARE CENTER IN EASTERN UTTAR PRADESH- AN OBSERVATIONAL STUDY

Authors

  • Dr. Priyanka Yadav
  • Dr Natasha Xess

DOI:

https://doi.org/10.53555/3nymjq07

Keywords:

Gestational Thrombocytopenia, COVID-19 Infection, Pregnancy, Thrombocytopenia Prevalence, Antenatal Women

Abstract

Background: Thrombocytopenia during pregnancy, particularly gestational thrombocytopenia, can complicate maternal and fetal outcomes. Recent evidence suggests a potential link between COVID-19 infection and hematological abnormalities, including thrombocytopenia. This study aims to assess the prevalence and severity of gestational thrombocytopenia among antenatal women with a history of COVID-19 infection in Eastern Uttar Pradesh.

Methods: An observational study was conducted at Government Medical College Azamgarh from January to December 2023, involving 1,000 antenatal women screened for thrombocytopenia. Participants with confirmed COVID-19 infection via RT-PCR or rapid antigen test were included. Data on platelet counts, obstetric outcomes, and complications were collected and analyzed.

Results: Of the 1,000 women screened, 250 (25%) exhibited thrombocytopenia, with 200 diagnosed as having gestational thrombocytopenia. The prevalence of thrombocytopenia was influenced by underlying conditions such as pregnancy-induced hypertension and infections. The majority had mild to moderate thrombocytopenia, with only a small fraction experiencing severe forms. Most women delivered vaginally, with a low incidence of complications such as postpartum hemorrhage and need for transfusions.

Conclusion: Gestational thrombocytopenia is prevalent among pregnant women with prior COVID-19 infection, predominantly presenting as mild to moderate. While severe complications are rare, close monitoring is essential to optimize maternal and fetal outcomes. Larger multicenter studies are warranted to further elucidate the relationship between COVID-19 and thrombocytopenia during pregnancy.

 

Author Biographies

  • Dr. Priyanka Yadav

    Assistant Professor, Government Medical College Azamgarh Uttar-Pradesh, India 

  • Dr Natasha Xess

    Junior Resident, Government Medical College Azamgarh Uttar-Pradesh, India

References

1.Katke RD, Gohil DP. Thrombocytopenia during pregnancy: an institutional based study. Int J Reprod Contracept Obstet Gynecol. 2014;3(4):947–951.

2.Sainio S, Kekomaki R, Riikonon S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand. 2000;79(9):744–749.

3.Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000;95(1):29–33. doi: 10.1016/s0029-7844(99)00537-2. 4.McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev. 2003;17(1):7–14. doi: 10.1016/s0268-960x(02)00056-5.

5.Ballem PJ. Hematological problems of pregnancy. Can Fam Physician. 1988;34:2531–2537.

6.Boehlen F. Thrombocytopenia during pregnancy: importance, diagnosis and management. Hamostaseologie. 2006;26(1):72–74.

7. Murillo-Llorente MT, Ventura I, Tomás-Aguirre F, Defez-Martin M, Martín-Díaz MI, Atienza-Ramirez S, Llorca-Colomer F, Asins-Cubells A, Legidos-García ME, Pérez-Bermejo M. Prevalence of Thrombocytopenia in Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2024 Aug 23;13(17):4980.

8. Mandloi Panwar N, Gangwani D, Mulye S, Singh N. Thrombocytopenia in pregnancy in pandemic era: an observational study. Int J Acad Med Pharm. 2023;5(1):516-520.

9. Singh, Sarika1,; Balhara, Kirti1; Oberoi, Mansi2. Prevalence and Etiology of Thrombocytopenia in Pregnant Women in a Tertiary Care Hospital in Delhi. MAMC Journal of Medical Sciences 7(3):p 239-243, Sep–Dec 2021. | DOI: 10.4103/mamcjms.mamcjms_52_21

10. Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D, Alimohammadi S, Basirjafari S, Mohammadi M, Rasmussen-Ivey C, Razizadeh MH, Nouri-Vaskeh M, Zarei M. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021 Sep;31(5):1-16. doi: 10.1002/rmv.2208. Epub 2021 Jan 2. PMID: 33387448; PMCID: PMC7883245.

11. Sultan, K., Khan, S., Tariq, S., Maaz, M., Shahmina, & Akhund, I. I. (2025). Association of Thrombocytopenia in Pregnant Women with COVID-19 Vaccination in the Post-COVID Era. Indus Journal of Bioscience Research, 3(6), 308-311.

12. Kumar S, Choudhary A, Shukla R, et al. Moderate to Severe Thrombocytopenia in Four Pregnant Women With Asymptomatic COVID-19 Infection. Cureus 13(10): e18531. doi:10.7759/cureus.18531

13 . Gernsheimer T, James AH, Stasi R. How I treat throm-bocytopenia in pregnancy. Blood. 2013; 121(1): 38-47. https://doi.org/10.1182/blood-2012-08-448944

14. Naz S, Bano I, Andleeb M, Waseem Z, Nisar Z. Moderate to Severe Thrombocytopenia and Survival Predictors in Pregnant Women during the Post-COVID-19 Pandemic Era. Pak Armed Forces Med J 2024; 74(3): 631-635. DOI: https://doi.org/10.51253/pafmj.v74i3. 10587

15. Bakshi RK, Kumar N, Srivastava A, Kumari S, Aggarwal P, Khan MA, Singh KJ. Decadal trends of maternal mortality and utilization of maternal health care services in India: Evidence from nationally representative data. J Family Med Prim Care. 2025 May;14(5):1807-1817. doi: 10.4103/jfmpc.jfmpc_916_24. Epub 2025 May 31. PMID: 40547788; PMCID: PMC12178503.

Downloads

Published

2025-12-01

How to Cite

Dr. Priyanka Yadav, & Dr Natasha Xess. (2025). PREVALENCE OF GESTATIONAL THROMBOCYTOPENIA IN ANTENATAL WOMEN FOLLOWING COVID-19 INFECTION AT A TERTIARY CARE CENTER IN EASTERN UTTAR PRADESH- AN OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 32(10), 1713-1718. https://doi.org/10.53555/3nymjq07
More Citation Formats

Issue

Section

Articles

How to Cite

Dr. Priyanka Yadav, & Dr Natasha Xess. (2025). PREVALENCE OF GESTATIONAL THROMBOCYTOPENIA IN ANTENATAL WOMEN FOLLOWING COVID-19 INFECTION AT A TERTIARY CARE CENTER IN EASTERN UTTAR PRADESH- AN OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 32(10), 1713-1718. https://doi.org/10.53555/3nymjq07